More answers like this
Grok 4.5Sep 30, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

[1][2][3]No, the US is not fully prepared for another major pandemic or widespread health crisis, though it is significantly better equipped in key technical areas than before COVID-19. Progress has been made in stockpiles, surveillance, medical countermeasures, and some coordination structures, but substantial gaps remain in leadership consistency, implementation of lessons learned, workforce capacity, state-level readiness, funding sustainability, and whole-of-government/biodefense architecture. These leave the country vulnerable to delays, inequities, supply shortages, and overwhelmed systems in a severe scenario (natural, accidental, or deliberate).[3][2]

Key Improvements Since COVID-19

Post-COVID investments and reforms (particularly under the Biden-Harris administration through early 2025) addressed some glaring pre-2020 weaknesses:

•Strategic National Stockpile (SNS): Dramatically expanded. It now holds roughly 70 times the pre-pandemic number of N95 respirators, 34 times the gloves, 50 times the isolation gowns, and 10 times the ventilators. It has supported responses to COVID remnants, H5N1, mpox, and other threats.[1]
•Surveillance and data systems: Electronic case reporting expanded from fewer than 200 healthcare facilities in 2020 to over 48,000 by 2024. Syndromic surveillance covers most hospital EDs; wastewater monitoring and other tools improved early detection. A “One CDC” data platform and other modernizations aim for better integration.[4]
•Medical countermeasures and R&D: Investments in mRNA and other platforms support faster vaccine/therapeutic development (aligned with “100 Days Mission” goals). Pre-pandemic influenza stockpiles and capabilities exist; responses to mpox and H5N1 demonstrated production and distribution scaling. BARDA and related efforts advanced manufacturing and stockpiling.[1]
•Coordination structures: The White House Office of Pandemic Preparedness and Response Policy (OPPR) was established as a permanent office. National Biodefense Strategy and Global Health Security Strategy updates provided frameworks. A detailed internal “playbook” was left for successors.[1]
•Global efforts: Leadership in the Pandemic Fund, vaccine sharing, partnerships expanded to more countries, and support for International Health Regulations (IHR) amendments. The US underwent a Joint External Evaluation (JEE) in 2024 using the updated tool incorporating COVID lessons.[5]
•Other: Expanded testing/manufacturing capacity lessons, community health workforce investments (via American Rescue Plan), and experience from multiple outbreaks (H5N1 in dairy/poultry, mpox, etc.).

These steps mean the US can detect and initially respond more effectively to many threats than in early 2020.

Persistent Gaps and Vulnerabilities

Independent assessments highlight unfinished business and systemic issues:

•GAO findings: As of mid-2024, ~220 of 428 COVID-related recommendations to agencies remained open. HHS leadership and coordination of public health emergencies stays on the High-Risk List. Specific needs include a national diagnostic testing strategy with clear roles, better collaboration forums, improved data sharing, supply chain resilience, and plans for medical countermeasures. Recent reports note ongoing deficiencies in testing coordination and emergency preparedness program alignment (e.g., PHEP and HPP).[2][6]
•Bipartisan Commission on Biodefense (2024 National Blueprint): Emphasized that the biological threat is “real and growing” and the nation remains “dangerously vulnerable.” It issued 36 recommendations and 185 action items covering leadership (stronger White House/National Security Advisor role), intelligence/attribution, science/tech, preparedness, detection/surveillance (e.g., replace outdated BioWatch), and response/recovery. Progress on prior recommendations has been incomplete; “immediate action” is needed.[3][7]
•State and local readiness: Trust for America’s Health (TFAH) Ready or Not reports (2025–2026) place many states in middle or low performance tiers across indicators like public health funding, lab surge capacity, hospital safety grades, flu vaccination, paid sick leave access, and avoidable mortality. Funding cuts in some states, workforce shortages, and uneven SLTT (state/local/tribal/territorial) capacities persist. High performers exist, but national response depends on the weakest links.[8][9]
•Workforce and funding: Public health staffing declines and burnout continue; monitoring of American Rescue Plan investments is needed. Sustained (not boom-bust) funding for CDC, ASPR/BARDA, and core programs is inconsistent. PAHPA reauthorization and related authorities face delays or temporary extensions.[10]
•JEE 2024 (WHO): Acknowledged US strengths (e.g., mass vaccination campaigns, strategies, lab systems in many areas) but recommended better alignment of political/legal/technical frameworks across regions/territories; extending robust preparedness to all SLTT levels; workforce strengthening (addressing declines and retention); and reviewing cost-effectiveness to reduce fragmentation/duplication.[10]
•Other issues: Public trust and communication challenges (evident in COVID); supply chain fragilities; hospital capacity strains in surges; coordination across health, agriculture (e.g., H5N1 in cattle), and other sectors; and equity gaps. Global Health Security Index (earlier versions ranked US highly on capabilities, but real-world COVID performance exposed political, trust, and execution shortfalls). Recent US News rankings placed the US around #18 for pandemic preparedness.[11]

Recent Context and Uncertainties (as of 2025–2026)

Administration transitions have affected continuity. OPPR staffing dropped sharply (to near-zero at points) before partial restarts amid outbreaks (measles, H5N1, others). Shifts include reduced global engagement in some areas, new policies on research oversight (e.g., gain-of-function restrictions raising expert concerns about preparedness impacts), and debates over funding/priorities. PAHPA and related reauthorizations remain critical. Experts (Stimson, CSIS, others) stress that “America First” approaches still require robust domestic biodefense and global containment to stop threats before they arrive.[12][13]

H5N1 monitoring, mpox responses, and flu seasons have tested systems with mixed results—improved tools help, but scaling, testing mandates, farmer trust, and cross-sector coordination show friction.

Bottom Line

The US has stronger tools, stockpiles, and experience than in 2019, enabling a more competent initial response to many scenarios. However, it is not fully prepared for a high-consequence novel pathogen with high transmissibility/virulence, especially if it strains hospitals, disrupts supply chains, or erodes trust. Success depends on sustained bipartisan investment, fully implementing open recommendations, strengthening SLTT capacities and the workforce, clear leadership/coordination, and maintaining (or rebuilding) public confidence. Preparedness is not a one-time achievement but an ongoing process; complacency or cuts reverse gains quickly. Independent bodies like GAO, the Bipartisan Commission, TFAH, and JEE consistently call for more action.

Citations (13)

  1. 1archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “[[1]](https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/)”

  2. 2gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “[[2]](https://www.gao.gov/products/gao-24-107175)”

  3. 3biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “[[3]](https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/)”

  4. 4cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “A “One CDC” data platform and other modernizations aim for better integration.”

  5. 5archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2024/12/11/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report-demonstrating-the-impact-of-united-states-leadership-and-investments/

    Backs: “The US underwent a Joint External Evaluation (JEE) in 2024 using the updated tool incorporating COVID lessons.”

  6. 6gao.govGovernment
    https://www.gao.gov/products/gao-25-106980

    Backs: “Recent reports note ongoing deficiencies in testing coordination and emergency preparedness program alignment (e.g., PHEP and HPP).”

  7. 7prnewswire.comNews and mediaquality 0.75
    https://www.prnewswire.com/news-releases/nation-dangerously-unprepared-for-deadly-outbreaks-and-biological-attacks-302136825.html

    Backs: “Progress on prior recommendations has been incomplete; “immediate action” is needed.”

  8. 8tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “High performers exist, but national response depends on the weakest links.”

  9. 9tfah.orgNonprofits and think tanks
    https://www.tfah.org/report-details/ready-or-not-2025-protecting-the-publics-health-from-diseases-disasters-and-bioterrorism/

    Backs: “High performers exist, but national response depends on the weakest links.”

  10. 10who.intGovernment
    https://iris.who.int/bitstream/handle/10665/380155/9789240105409-eng.pdf?sequence=1sask

    Backs: “PAHPA reauthorization and related authorities face delays or temporary extensions.”

  11. 11nypost.comNews and mediaquality 0.64
    https://nypost.com/2026/05/14/health/how-prepared-is-the-us-for-another-pandemic-inside-new-rankings/

    Backs: “Recent US News rankings placed the US around #18 for pandemic preparedness.”

  12. 12stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “Experts (Stimson, CSIS, others) stress that “America First” approaches still require robust domestic biodefense and global containment to stop threats before they arrive.”

  13. 13justthenews.comNews and mediaquality 0.57
    https://justthenews.com/government/white-house/after-outbreaks-trump-admin-restarts-office-pandemic-preparedness-and

    Backs: “Experts (Stimson, CSIS, others) stress that “America First” approaches still require robust domestic biodefense and global containment to stop threats before they arrive.”